Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 4/20 | 0.33 |
| ▸ | HTR2B | P41595 | 4/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | PRNP | P04156 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25816153 | 0.82 | PDE5A (0.36) | KDM1AALDH1A1SLC6A3POLBHDAC4 | |
| SCHEMBL5970111 | 0.75 | SLC6A2 (0.46) | KDM1AALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL2470428 | 0.75 | SLC6A2 (0.46) | KDM1AALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5969949 | 0.75 | SLC6A2 (0.46) | KDM1AALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL28226011 | 0.71 | AADAT (0.38) | ALDH1A1HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL1721723 | 0.69 | ALDH1A1 (0.47) | ALDH1A1FABP5POLBCASP6CTDSP1 | |
| SCHEMBL20480557 | 0.67 | HTR1A (0.38) | ALDH1A1HTR2BPOLBCASP6CTDSP1 | |
| SCHEMBL19839756 | 0.67 | GID4 (0.44) | ALDH1A1FABP5HDAC4 | |
| SCHEMBL31110943 | 0.66 | PARP1 (0.36) | ALDH1A1HTR2BPOLBCASP6CTDSP1 | |
| SCHEMBL28226003 | 0.66 | AADAT (0.38) | ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12448363-B2 | Kinase inhibitors | VIDYA THERAPEUTICS, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| CN-115867346-B | Kinase inhibitors | GB005股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20230219923-A1 | KINASE INHIBITORS | VIDYA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230219923-A1 | KINASE INHIBITORS | VIDYA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230219923-A1 | KINASE INHIBITORS | VIDYA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| EP-4157446-A1 | KINASE INHIBITORS | GB002, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| CN-115867346-A | Kinase inhibitors | GB005股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12448363-B2 | Kinase inhibitors | BTK, ABL1, LYN | KDM1A 925/4885ALDH1A1 4364/4885FABP5 4162/4885 |
| US-20230219923-A1 | KINASE INHIBITORS | BTK, ABL1, LYN | KDM1A 925/4885ALDH1A1 4364/4885FABP5 4162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.